[{"type": "title", "data": "TM Emicizumab (Hemlibra) Hemophilia A Prophylaxis (Module)"}, {"type": "category", "data": "Blood Products"}, {"type": "note", "data": "Consult with the Bleeding Disorder Program prior to ordering", "value": ""}, {"type": "note", "data": "This product requires a Canadian Blood Services contract", "value": ""}, {"type": "note", "data": "Do not order PTT and Factor VIII Level if administering this product as they will be unreliable", "value": ""}, {"type": "note", "data": "Emicizumab (Hemlibra)", "value": ""}, {"type": "note", "data": "Emicizumab (Hemlibra) - Fact Sheet for PHC sites", "value": ""}, {"type": "note", "data": "Must be drawn using a blunt filter needle", "value": ""}, {"type": "order", "data": "Administer - Emicizumab", "value": "checked"}, {"type": "sentence", "data": "mg, subcutaneous, Administer over: Refer to Fact Sheet/Product Monograph, once, Patient may self-administer. Must be drawn using a blunt filter needle"}, {"type": "sentence", "data": "mg, subcutaneous, Administer over: Refer to Fact Sheet/Product Monograph, qweek, Patient may self-administer. Must be drawn using a blunt filter needle"}, {"type": "sentence", "data": "mg, subcutaneous, Administer over: Refer to Fact Sheet/Product Monograph,  q2week, Patient may self-administer. Must be drawn using a blunt filter needle"}, {"type": "sentence", "data": "mg, subcutaneous, Administer over: Refer to Fact Sheet/Product Monograph,  q4week, Patient may self-administer. Must be drawn using a blunt filter needle"}, {"type": "order", "data": "Communication Order", "value": "checked"}, {"type": "sentence", "data": "If the patient exhibits signs or symptoms of a Transfusion Reaction, Print Transfusion Reaction Form from FormFast and follow your transfusion reaction guideline.\u00a0 Notify provider of the transfusion reaction to obtain further care instructions."}]
